<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The tafazzin gene (TAZ) is located at Xq28 and encodes a protein involved in the transacylation of <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, an essential <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16247">phospholipid</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in TAZ are associated with <z:e sem="disease" ids="C0574083" disease_type="Disease or Syndrome" abbrv="">Barth syndrome</z:e> (BTHS), the <z:hpo ids='HP_0001417'>X-linked</z:hpo> recessive condition with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, <z:hpo ids='HP_0003756'>skeletal myopathy</z:hpo>, <z:hpo ids='HP_0001510'>growth retardation</z:hpo>, <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and <z:hpo ids='HP_0001992'>organic aciduria</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>TAZ mutations also contribute to left ventricular noncompaction (LVNC), a <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> characterized by loose, trabeculated myocardium </plain></SENT>
<SENT sid="3" pm="."><plain>CASE REPORT: We report a family with a novel TAZ mutation and the clinical spectrum from severe BTHS in an infant to <z:hpo ids='HP_0003756'>skeletal myopathy</z:hpo> with LVNC in an adult, the oldest individual with BTHS reported </plain></SENT>
<SENT sid="4" pm="."><plain>The proband is a 51-year-old male with <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> since early childhood </plain></SENT>
<SENT sid="5" pm="."><plain>He remained stable until the age of 43 </plain></SENT>
<SENT sid="6" pm="."><plain>His initial evaluations found LVNC and borderline <z:hpo ids='HP_0001875'>neutropenia</z:hpo> with no elevation of urine 3-methylglutaconic acid </plain></SENT>
<SENT sid="7" pm="."><plain>The proband's great nephew is a 3-year-old who presented at birth with <z:hpo ids='HP_0011968'>poor feeding</z:hpo>, <z:mp ids='MP_0004144'>hypotonia</z:mp>, <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>At three months he was admitted with <z:hpo ids='HP_0001508'>failure to thrive</z:hpo>, <z:hpo ids='HP_0001254'>lethargy</z:hpo> and <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> due to <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Cardiac studies revealed <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> with a spongiform trabeculated pattern of the left ventricle </plain></SENT>
<SENT sid="10" pm="."><plain>Laboratory studies showed cyclic <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and elevated urine 3-methylglutaconic and 3-methylglutaric acids </plain></SENT>
<SENT sid="11" pm="."><plain>At age 11months the patient had a heart transplant </plain></SENT>
<SENT sid="12" pm="."><plain>We conducted sequence analysis of the TAZ gene for two affected individuals, the proband first and then his great-nephew </plain></SENT>
<SENT sid="13" pm="."><plain>A novel, hemizygous nonsense mutation in TAZ exon 7 (c.583G&gt;T, p.Gly195X) was detected </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: At his current age of 51years-old, the proband is the oldest surviving individual reported with a confirmed molecular diagnosis and features of <z:e sem="disease" ids="C0574083" disease_type="Disease or Syndrome" abbrv="">Barth syndrome</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Further studies will be conducted to identify the genetic modifying factor(s) associated with the wide phenotypic range seen in this family </plain></SENT>
</text></document>